>Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, but **experts say patients shouldn’t expect it to be available for at least a few months**.
>
>As of Dec. 29, Health Canada had received nine submissions seeking approval to make semaglutide, the active ingredient in Ozempic and Wegovy, the brand-name diabetes and weight-loss drugs manufactured by Novo Nordisk.
>
>“Health Canada understands that there is considerable interest in lowering costs associated with this highly prescribed drug by introducing generic versions,” spokesperson Mark Johnson said in an email to The Canadian Press.
>
>Sandoz Canada, Apotex, Teva Canada, Taro Pharmaceuticals and Aspen Pharmacare Canada have all applied for Health Canada authorization, according to its list of generic submissions.
Loweffort2025 on
To bad its used to make people look like skeletons and not for its proper use.
myairblaster on
Manufacturing peptides takes time, and production can only begin once Health Canada approves the facility and its antiseptic practices for any injectable medication, even if those pharmaceutical companies are already making injectable medications. You can also expect that any compounding pharmacy with antiseptic protocols and the right machinery will ramp up production, and we can soon see many of them advertising it within the next few months.
Krommander on
C’est une bonne nouvelle ça! Tellement de gens souffrent des conséquences du surpoids!
RydNightwish on
As someone who was obese and who put in the work to diet, eat healthier and commit to an exercise routine losing 100 plus pounds well after this stuff first appeared…I don’t respect people using these drugs solely as a short cut for weight loss and I won’t commend them.
Its like using AI to write your term papers. Do it right the first time or dont be surprised you’ll have to do it again a second or third time because you truly learned nothing the first time around.
CatchUpBud on
In the meantime there are a plethora of grey market sources peddling it along with more efficient products.
Bootz85 on
The masses will benefit from this but the real glp-1 that doesn’t get the attention it should are trizepatides and soon retatrutide will get FDA approval and that’ll change the glp-1 game all over again.
Lilly is building a $9B plant in Indiana which is anticipated to produce their retatrutide product. Oz is like a 90s civic while reta is a Tesla, shits going to change quick with glp-1’s but at least Canadians will benefit from generic glp-1’s this year.
A_Pointy_Rock on
Iirc, this is because they refused to pay a ~$800 late fee in renewing their patent.
jayhasbigvballs on
The increased accessibility to these drugs will be massively beneficial to the Canadian healthcare system. If it’s possible to lower rates of obesity and overweight, it’s safe to assume we will also see reduced rates of associated afflictions like hypertension, dyslipidemia, type 2 diabetes, sleep apnea and others, which will also mean we should see a reduction in associated negative outcomes like heart attack, stroke, liver disease, etc. Ifeally this will mean fewer hospitalizations and less burden on the healthcare system.
Lisan_Al-NaCL on
I suspect companies planning on entering the Canadian market have been setting up production in Asia for months.
Fun fact: most pharmaceuticals are manufactured in Asia (China and India).
I’d honestly be surprised if generic ozempic for Canada wasnt already made and just waiting for the official date when its legal to import/sell in Canada.
[deleted] on
[deleted]
AlprazolamHunt45 on
This stuff has actually been instrumental in helping cure my alcohol issues. Going to be nice not to pay nearly $500 a month for it. Hope NOVO enjoyed the profits well they could. lol
Furycrab on
Major insurers have already put Ozempic under review anticipating this change. With review periods set to end in 6-9 months. Insurers can’t really stall that much longer without having an appropriate alternative treatment plan to suggest. One big insurer I know has that review set to end anywhere from May to July.
I’d place the spread to when Generics might be hitting pharmacy shelves around June.
wtfman1988 on
How much is Ozempic now and how much could a generic realistically cost?
14 Comments
>Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, but **experts say patients shouldn’t expect it to be available for at least a few months**.
>
>As of Dec. 29, Health Canada had received nine submissions seeking approval to make semaglutide, the active ingredient in Ozempic and Wegovy, the brand-name diabetes and weight-loss drugs manufactured by Novo Nordisk.
>
>“Health Canada understands that there is considerable interest in lowering costs associated with this highly prescribed drug by introducing generic versions,” spokesperson Mark Johnson said in an email to The Canadian Press.
>
>Sandoz Canada, Apotex, Teva Canada, Taro Pharmaceuticals and Aspen Pharmacare Canada have all applied for Health Canada authorization, according to its list of generic submissions.
To bad its used to make people look like skeletons and not for its proper use.
Manufacturing peptides takes time, and production can only begin once Health Canada approves the facility and its antiseptic practices for any injectable medication, even if those pharmaceutical companies are already making injectable medications. You can also expect that any compounding pharmacy with antiseptic protocols and the right machinery will ramp up production, and we can soon see many of them advertising it within the next few months.
C’est une bonne nouvelle ça! Tellement de gens souffrent des conséquences du surpoids!
As someone who was obese and who put in the work to diet, eat healthier and commit to an exercise routine losing 100 plus pounds well after this stuff first appeared…I don’t respect people using these drugs solely as a short cut for weight loss and I won’t commend them.
Its like using AI to write your term papers. Do it right the first time or dont be surprised you’ll have to do it again a second or third time because you truly learned nothing the first time around.
In the meantime there are a plethora of grey market sources peddling it along with more efficient products.
The masses will benefit from this but the real glp-1 that doesn’t get the attention it should are trizepatides and soon retatrutide will get FDA approval and that’ll change the glp-1 game all over again.
Lilly is building a $9B plant in Indiana which is anticipated to produce their retatrutide product. Oz is like a 90s civic while reta is a Tesla, shits going to change quick with glp-1’s but at least Canadians will benefit from generic glp-1’s this year.
Iirc, this is because they refused to pay a ~$800 late fee in renewing their patent.
The increased accessibility to these drugs will be massively beneficial to the Canadian healthcare system. If it’s possible to lower rates of obesity and overweight, it’s safe to assume we will also see reduced rates of associated afflictions like hypertension, dyslipidemia, type 2 diabetes, sleep apnea and others, which will also mean we should see a reduction in associated negative outcomes like heart attack, stroke, liver disease, etc. Ifeally this will mean fewer hospitalizations and less burden on the healthcare system.
I suspect companies planning on entering the Canadian market have been setting up production in Asia for months.
Fun fact: most pharmaceuticals are manufactured in Asia (China and India).
I’d honestly be surprised if generic ozempic for Canada wasnt already made and just waiting for the official date when its legal to import/sell in Canada.
[deleted]
This stuff has actually been instrumental in helping cure my alcohol issues. Going to be nice not to pay nearly $500 a month for it. Hope NOVO enjoyed the profits well they could. lol
Major insurers have already put Ozempic under review anticipating this change. With review periods set to end in 6-9 months. Insurers can’t really stall that much longer without having an appropriate alternative treatment plan to suggest. One big insurer I know has that review set to end anywhere from May to July.
I’d place the spread to when Generics might be hitting pharmacy shelves around June.
How much is Ozempic now and how much could a generic realistically cost?